Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation...
Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Long-chain fatty acid oxidation disorders (LC-FAOD) are a group of rare inborn errors of metabolism with autosomal recessive inheritance that may cause life-threatening events. Treatment with triheptanoin, a synthetic seven-carbon fatty acid triglyceride compound with an anaplerotic effect, seems beneficial, but clinical experience is limited. We r...
Alternative Titles
Full title
Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b6eb7eb0d7cd461bb1fbabb3a91cb8b1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b6eb7eb0d7cd461bb1fbabb3a91cb8b1
Other Identifiers
ISSN
1750-1172
E-ISSN
1750-1172
DOI
10.1186/s13023-020-01635-x
